Search filters

List of works by Bora Lim

A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus

scientific article published on 14 January 2015

A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer

scientific article published on 03 November 2020

A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cells

scientific article published on 18 December 2015

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment

scientific article published on 17 May 2019

Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.

scientific article published on 16 March 2017

Androgen receptor expression on circulating tumor cells in metastatic breast cancer.

scientific article published on 28 September 2017

Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

scientific article published on 02 March 2019

Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key

scientific article published on 01 August 2018

Breast tumours maintain a reservoir of subclonal diversity during expansion

scientific article published on 24 March 2021

Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer

scientific article published on 28 October 2015

Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer

scientific article published on 01 July 2019

Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy.

scientific article published on 6 September 2014

Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer "The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Localized Disease".

scientific article published on January 2015

Current challenges of metastatic breast cancer.

scientific article published on 08 December 2016

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy

scientific article

Development of CNS metastases and survival in patients with inflammatory breast cancer

article

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

scientific article published on 12 April 2022

Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer

scientific article published on 4 January 2018

Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer

scientific article published on 8 March 2017

Expression of Programmed Death Ligand 1 (PD-L1) in Posttreatment Primary Inflammatory Breast Cancers and Clinical Implications.

scientific article published on 7 February 2018

FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic colon cancer ⬇️

scientific article published on June 13, 2013

Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10.

scientific article published on 13 February 2015

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.

scientific article published on 2 May 2017

Imaging features of triple-negative breast cancers according to androgen receptor status

scientific article published on 21 March 2019

Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypes

scientific article published on 18 June 2018

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

scientific article

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.

scientific article published on 6 April 2018

Lung mesenchymal cells elicit lipid storage in neutrophils that fuel breast cancer lung metastasis

scientific article published on 21 September 2020

MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer

scientific article published on 30 May 2017

Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.

scientific article published on 9 November 2015

Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience

scientific article published on 10 July 2018

Novel therapeutic strategies in the treatment of triple-negative breast cancer

scientific article

ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non-Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms

scientific article published on 19 April 2017

Prognostic significance of high metabolic activity in breast cancer: PET signature in breast cancer

scientific article published on 15 February 2019

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy

scientific article published on 12 November 2020

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype

scientific article published in PLoS ONE

Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer.

scientific article published in October 2017

Role of MR Imaging in Neoadjuvant Therapy Monitoring

scientific article published on 02 March 2018

Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer

scientific article published on 01 September 2018

Targeting Signaling Pathways in Inflammatory Breast Cancer

scientific article published on 01 September 2020

Targeting TRAIL in the treatment of cancer: new developments.

scientific article published on 25 May 2015

Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy

scientific article published on 24 May 2019

The Actual Role of Receptors as Cancer Markers, Biochemical and Clinical Aspects: Receptors in Breast Cancer.

scientific article published on January 2015

Thrombocytosis as a prognostic factor in inflammatory breast cancer

scientific article published on 22 August 2017

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.

scientific article

Update on Clinical Trials: Genetic Targets in Breast Cancer ⬇️

scientific article published on January 1, 2013

Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer

scientific article published on 24 October 2020

Paulina is supported by:

About Paulina

Help